Okoń K - Search Results

1

In Vitro Spectroscopy-Based Profiling of Urothelial Carcinoma: A Fourier Transform Infrared and Raman Imaging Study.

Kujdowicz M, Placha W, Mech B, Chrabaszcz K, Okoń K, Malek K. Kujdowicz M, et al. Among authors: okon k. Cancers (Basel). 2021 Jan 2;13(1):123. doi: 10.3390/cancers13010123. Cancers (Basel). 2021. PMID: 33401726 Free PMC article.

2

FTIR Spectroscopic Imaging Supports Urine Cytology for Classification of Low- and High-Grade Bladder Carcinoma.

Kujdowicz M, Mech B, Chrabaszcz K, Chlosta P, Okon K, Malek K. Kujdowicz M, et al. Among authors: okon k. Cancers (Basel). 2021 Nov 16;13(22):5734. doi: 10.3390/cancers13225734. Cancers (Basel). 2021. PMID: 34830887 Free PMC article.

3

Evaluation of grade and invasiveness of bladder urothelial carcinoma using infrared imaging and machine learning.

Kujdowicz M, Perez-Guaita D, Chlosta P, Okon K, Malek K. Kujdowicz M, et al. Among authors: okon k. Analyst. 2023 Jan 16;148(2):278-285. doi: 10.1039/d2an01583h. Analyst. 2023. PMID: 36525038

4

Fourier transform IR imaging of primary tumors predicts lymph node metastasis of bladder carcinoma.

Kujdowicz M, Perez-Guaita D, Chlosta P, Okon K, Malek K. Kujdowicz M, et al. Among authors: okon k. Biochim Biophys Acta Mol Basis Dis. 2023 Dec;1869(8):166840. doi: 10.1016/j.bbadis.2023.166840. Epub 2023 Aug 7. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 37558006 Free article.

5

Cadmium in urothelial carcinoma of the bladder.

Golabek T, Darewicz B, Kudelski J, Socha K, Markiewicz-Zukowska R, Chlosta P, Okoń K, Borawska M. Golabek T, et al. Among authors: okon k. Pol J Pathol. 2014 Mar;65(1):55-9. doi: 10.5114/pjp.2014.42670. Pol J Pathol. 2014. PMID: 25119010 Free article.

6

HER-3 expression in HER-2-amplified breast carcinoma.

Czopek J, Pawlęga J, Fijorek K, Püsküllüoğlu M, Różanowski P, Okoń K. Czopek J, et al. Among authors: okon k. Contemp Oncol (Pozn). 2013;17(5):446-9. doi: 10.5114/wo.2013.38564. Epub 2013 Nov 14. Contemp Oncol (Pozn). 2013. PMID: 24596534 Free PMC article.

7

Patterns of gene expression characterize T1 and T3 clear cell renal cell carcinoma subtypes.

Borys AM, Seweryn M, Gołąbek T, Bełch Ł, Klimkowska A, Totoń-Żurańska J, Machlowska J, Chłosta P, Okoń K, Wołkow PP. Borys AM, et al. Among authors: okon k. PLoS One. 2019 May 31;14(5):e0216793. doi: 10.1371/journal.pone.0216793. eCollection 2019. PLoS One. 2019. PMID: 31150395 Free PMC article.

8

Selected morphologic features influencing the prognosis of conventional renal cell carcinomas co-expressing P53 and MDM2.

Hejnold M, Dyduch G, Białas M, Demczuk S, Ryś J, Szopiński T, Chłosta P, Okoń K. Hejnold M, et al. Among authors: okon k. Pol J Pathol. 2014 Mar;65(1):29-33. doi: 10.5114/pjp.2014.42666. Pol J Pathol. 2014. PMID: 25119006 Free article.

9

Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.

Hejnold M, Dyduch G, Białas M, Demczuk S, Ryś J, Chłosta P, Szopiński T, Okoń K. Hejnold M, et al. Among authors: okon k. Pol J Pathol. 2014 Jun;65(2):113-9. doi: 10.5114/pjp.2014.43960. Pol J Pathol. 2014. PMID: 25119170 Free article.

10

ERG positive prostatic cancer may show a more angiogenetic phenotype.

Strzępek A, Kaczmarczyk K, Białas M, Szpor J, Dyduch G, Szopiński T, Chłosta P, Okoń K. Strzępek A, et al. Among authors: okon k. Pathol Res Pract. 2014 Dec;210(12):897-900. doi: 10.1016/j.prp.2014.07.009. Epub 2014 Aug 9. Pathol Res Pract. 2014. PMID: 25220615

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page